GR3023717T3 - Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv. - Google Patents
Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv.Info
- Publication number
- GR3023717T3 GR3023717T3 GR970401358T GR970401358T GR3023717T3 GR 3023717 T3 GR3023717 T3 GR 3023717T3 GR 970401358 T GR970401358 T GR 970401358T GR 970401358 T GR970401358 T GR 970401358T GR 3023717 T3 GR3023717 T3 GR 3023717T3
- Authority
- GR
- Greece
- Prior art keywords
- protein
- pct
- native
- hiv
- membrane proteins
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 108010065667 Viral Matrix Proteins Proteins 0.000 title abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 3
- 108020001580 protein domains Proteins 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 208000030507 AIDS Diseases 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 230000029087 digestion Effects 0.000 abstract 1
- 231100000676 disease causative agent Toxicity 0.000 abstract 1
- 108010078428 env Gene Products Proteins 0.000 abstract 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4301017 | 1993-01-16 | ||
PCT/DE1994/000022 WO1994016081A1 (de) | 1993-01-16 | 1994-01-12 | Verfahren zur gewinnung nativer domänen viraler membranproteine, deren verwendung, insbesondere als impfstoff gegen hiv |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3023717T3 true GR3023717T3 (en) | 1997-09-30 |
Family
ID=6478309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR970401358T GR3023717T3 (en) | 1993-01-16 | 1997-06-10 | Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv. |
Country Status (9)
Country | Link |
---|---|
US (1) | US6140059A (el) |
EP (1) | EP0679187B2 (el) |
JP (1) | JP3658690B2 (el) |
AT (1) | ATE153380T1 (el) |
DE (2) | DE4400659C2 (el) |
DK (1) | DK0679187T4 (el) |
ES (1) | ES2102815T5 (el) |
GR (1) | GR3023717T3 (el) |
WO (1) | WO1994016081A1 (el) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2781676B1 (fr) * | 1998-07-31 | 2004-04-02 | Pasteur Merieux Serums Vacc | Trimere du produit d'expression du gene env de hiv |
EP1141313A2 (en) * | 1998-12-31 | 2001-10-10 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
EP1141314A2 (en) * | 1998-12-31 | 2001-10-10 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
ES2299276T3 (es) * | 1998-12-31 | 2008-05-16 | Novartis Vaccines And Diagnostics, Inc. | Polipeptidos env del vih modificados. |
WO2001019958A2 (en) * | 1999-09-17 | 2001-03-22 | Dana-Farber Cancer Institute, Inc. | Stabilized soluble glycoprotein trimers |
US7179468B1 (en) | 2000-06-08 | 2007-02-20 | Cornell Research Foundation, Inc. | Antigen for developing neutralizing antibodies to human immunodeficiency virus |
US20030198621A1 (en) * | 2001-07-05 | 2003-10-23 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof |
CA2452015C (en) | 2001-07-05 | 2012-07-03 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
US20030170614A1 (en) * | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
AU2002316578A1 (en) * | 2001-08-31 | 2003-03-18 | Chiron Corporation | Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
CA2520604A1 (en) * | 2003-05-09 | 2004-11-25 | Research Development Foundation | Insertion of furin protease cleavage sites in membrane proteins and uses thereof |
US7358334B1 (en) | 2003-11-14 | 2008-04-15 | Jay W Chaplin | B cell-targeted toxins for humoral immune response reduction and methods of use thereof |
US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
US9216212B2 (en) | 2005-08-05 | 2015-12-22 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
US9102734B2 (en) * | 2009-03-10 | 2015-08-11 | Baylor Research Institute | Fusion proteins comprising antibody and HPV E6 and E7 antigens |
US8580270B2 (en) * | 2008-09-30 | 2013-11-12 | University Of Massachusetts | Respiratory synctial virus (RSV) sequences for protein expression and vaccines |
PT2406286T (pt) * | 2009-03-10 | 2016-08-19 | Baylor Res Inst | Anticorpos anti-cd40 e seus usos |
MX2011009439A (es) | 2009-03-10 | 2013-06-18 | Baylor Res Inst | Vacunas con especificidad de objetivo hacia celula presentadora de antigeno. |
CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
EP2688592A4 (en) | 2011-03-25 | 2015-07-22 | Baylor Res Inst | COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST HEPATITIS C VIRUS |
HUE037408T2 (hu) | 2011-06-10 | 2018-08-28 | Univ Oregon Health & Science | CMV glikoproteinek és rekombináns vektorok |
EP2586461A1 (en) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Viral particles derived from an enveloped virus |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
AU2015204503B2 (en) | 2014-01-13 | 2020-07-09 | Baylor Research Institute | Novel vaccines against HPV and HPV-related diseases |
EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
EP3072901A1 (en) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
US10610585B2 (en) | 2017-09-26 | 2020-04-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and compositions for treating and preventing HIV |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3731874A1 (de) * | 1987-09-18 | 1989-03-30 | Schering Ag | Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen |
IL89567A0 (en) * | 1988-03-28 | 1989-09-10 | Univ Leland Stanford Junior | Mutated hiv envelope protein |
JP2624894B2 (ja) † | 1990-03-09 | 1997-06-25 | カイロン コーポレイション | 天然のコンホメーションを保持している精製gp120組成物 |
FR2676071B1 (fr) * | 1991-05-02 | 1994-11-18 | Transgene Sa | Nouveau variant gp160 non-clivable, soluble, de forme hybride. |
-
1994
- 1994-01-12 AT AT94904568T patent/ATE153380T1/de not_active IP Right Cessation
- 1994-01-12 DE DE4400659A patent/DE4400659C2/de not_active Expired - Fee Related
- 1994-01-12 DE DE59402827T patent/DE59402827D1/de not_active Expired - Fee Related
- 1994-01-12 WO PCT/DE1994/000022 patent/WO1994016081A1/de active IP Right Grant
- 1994-01-12 JP JP51558794A patent/JP3658690B2/ja not_active Expired - Fee Related
- 1994-01-12 US US08/448,619 patent/US6140059A/en not_active Expired - Fee Related
- 1994-01-12 DK DK94904568T patent/DK0679187T4/da active
- 1994-01-12 EP EP94904568A patent/EP0679187B2/de not_active Expired - Lifetime
- 1994-01-12 ES ES94904568T patent/ES2102815T5/es not_active Expired - Lifetime
-
1997
- 1997-06-10 GR GR970401358T patent/GR3023717T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP3658690B2 (ja) | 2005-06-08 |
DE59402827D1 (de) | 1997-06-26 |
EP0679187B1 (de) | 1997-05-21 |
DE4400659A1 (de) | 1994-07-21 |
DE4400659C2 (de) | 1995-07-27 |
JPH08505769A (ja) | 1996-06-25 |
WO1994016081A1 (de) | 1994-07-21 |
DK0679187T4 (da) | 2001-09-17 |
EP0679187A1 (de) | 1995-11-02 |
ES2102815T3 (es) | 1997-08-01 |
US6140059A (en) | 2000-10-31 |
ATE153380T1 (de) | 1997-06-15 |
DK0679187T3 (da) | 1997-12-08 |
EP0679187B2 (de) | 2001-07-04 |
ES2102815T5 (es) | 2001-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3023717T3 (en) | Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv. | |
EP0280710A4 (en) | DNA ENCODING THE T CELL SURFACE PROTEIN T4 AND USE OF T4 FRAGMENTS IN THE TREATMENT OF AIDS. | |
DK33190A (da) | Hiv-3 retrovirus og anvendelse heraf | |
AU1568400A (en) | Intervertebral disc prosthesis | |
DK0518999T3 (da) | Proteinhydrolysater | |
ES2013346A6 (es) | Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles. | |
WO2021000968A3 (zh) | 一种用于预防SARS-CoV-2感染的腺病毒载体疫苗 | |
ES2010727A6 (es) | Metodo para producir lineas celulares que producen anticuerpos monoclonales reactivos frente a determinantes antigenicos de gp110 o de p25 de hiv. | |
EP0342860A3 (en) | Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use | |
JP2002533125A5 (el) | ||
Weiss et al. | Recombinant HIV-1 nucleocapsid protein p15 produced as a fusion protein with glutathione S-transferase in Escherichia coli mediates dimerization and enhances reverse transcription of retroviral RNA | |
EP0272858A3 (en) | Recombinant hiv envelope proteins produced in insect cells | |
AU1463097A (en) | Helicobacter pylori bacterioferritin | |
ES2010231A6 (es) | Metodo para fabricar particulas de proteinas de fusion y metodo para expresar estas proteinas. | |
US5354683A (en) | Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation | |
JP3453611B2 (ja) | ハイブリッド形態の新規可溶性、非開裂性gp160変異体 | |
HUP0001991A2 (hu) | Varicella Zoster vírus 63-as géntermékkel szembeni vakcinák | |
AUPM772494A0 (en) | Improvements in production of proteins in host cells | |
IL158981A0 (en) | Tsg101 as inhibitor of hiv production | |
DE69021886D1 (de) | Äusseres membranprotein p1 und peptide von haemophilus influenzae typ b. | |
BE1000167A4 (fr) | Antigene du virus de l'hepatite b et procede pour sa production. | |
EP1456382A4 (en) | GLYCOSYLATION RESISTANT CYANOVIRINS AND CONJUGATES, COMPOSITIONS, NUCLEIC ACIDS, VECTORS, HOST, ASSOCIATED CELLS, AND METHODS OF OBTAINING AND USING NON-GLYCOSYLATED CYANOVIRINS | |
HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
AP2005A (en) | Process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype C isolates, their genes and modifications and derivatives thereof. | |
ESTABLE et al. | Sequence Note: Distinct Clustering of HIV Type 1 Sequences Derived from Injection versus Noninjection Drug Users in Vancouver, Canada |